Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression

Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression

Bibliographic Details
Main Authors:	Ai-Tram N. Bui, BA, Caroline A. Nelson, MD, Christine G. Lian, MD, Alvaro Laga Canales, MD, MMSC, Nicole R. LeBoeuf, MD, MPH
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	JAAD Case Reports
Subjects:	autoimmunity checkpoint inhibition cutaneous toxicities eosinophilic fasciitis immune checkpoint inhibitors immune-related adverse event
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512620302800

Similar Items

Eosinophilic fasciitis in association with nivolumab: The importance of eosinophilia
by: Gabriela Pabón-Cartagena, MD, et al.
Published: (2020-12-01)

Eosinophilic Fasciitis Responds Well to Steroids and Methotrexate
by: Asmaa Sabr Mahdi1*,, et al.
Published: (2019-11-01)

Successful treatment of refractory eosinophilic fasciitis with reslizumab
by: Mahta Mortezavi, MD, et al.
Published: (2020-09-01)

Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors
by: Sonja C. S. Simon, et al.
Published: (2020-01-01)

A rarer association of eosinophilic fasciitis
by: U Namita, et al.
Published: (2019-01-01)

Skin puckering and edema during durvalumab therapy
by: Brianna Olamiju, BA, et al.
Published: (2021-01-01)

Eosinophilic airway inflammation and eosinophilic chronic rhinosinusitis during nivolumab and ipilimumab
by: Hirofumi Watanabe, et al.
Published: (2020-10-01)

A Case of Nivolumab-Induced Cutaneous Toxicity with Multiple Morphologies
by: Emily D. Nguyen, et al.
Published: (2020-01-01)

Atypical Presenting Symptoms of Acute Onset Acquired Haemophilia with Eosinophilic Fasciitis
by: Yuto Nakakubo, et al.
Published: (2020-06-01)

A “groovy” diagnosis: Eosinophilic fasciitis
by: Peter Korsten
Published: (2020-12-01)

Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure
by: Warren H. Chan, MS, et al.
Published: (2018-03-01)

Eosinophilic Fasciitis: A Case Report and Literature Review
by: Charussri Leeyaphan, et al.
Published: (2020-07-01)

Diagnostic utility of Magnetic Ressonance Imaging in Eosinophilic Fasciitis
by: Alexandra Daniel, et al.
Published: (2017-07-01)

Eosinophilic Fasciitis Associated with Myositis
by: Yuko Adachi, et al.
Published: (2015-04-01)

Eosinophilic fasciitis after parasite infection
by: Marta Oliveira, et al.
Published: (2016-03-01)

Immune checkpoint inhibitors‐induced eosinophilic pneumonia: A case report
by: Kanako Hara, et al.
Published: (2021-03-01)

Eosinophilic Fasciitis: an Atypical Presentation of a Rare Disease
by: Sabrina Poradosu, et al.
Published: (2015-04-01)

Juvenile eosinophilic fasciitis presenting with polyarthritis and koebner's phenomenon
by: Zakiya Saleh Al Mosawi, et al.
Published: (2018-01-01)

Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab
by: Andrew Hantel, et al.
Published: (2018-07-01)

Two case reports and a literature review on eosinophilic fasciitis
by: Diana Mazilu, et al.
Published: (2021-03-01)

Association Of Eosinophilic Fasciitis With Morphea
by: Zisova Lilia G., et al.
Published: (2014-09-01)

Scleroderma mimicker – Eosinophilic fasciitis
by: Debanjali Sinha, et al.
Published: (2017-01-01)

Eosinophilic fasciitis
by: Karolina Niklas, et al.
Published: (2015-01-01)

A rare case of unilateral eosinophilic fasciitis associated with ipsilateral extragenital lichen sclerosus
by: Aseem Sharma, et al.
Published: (2016-01-01)

Eosinophilic fasciitis (Shulman’s disease): review and comparative evaluation of seven patients
by: Joana Urzal, et al.
Published: (2019-04-01)

The place of <sup>18</sup>F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report
by: N. Belfeki, et al.
Published: (2021-01-01)

Nivolumab-associated cutaneous T-cell lymphoma
by: Jennifer A. Marks, MD, et al.
Published: (2021-03-01)

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
by: Mathew R. Birnbaum, BS, et al.
Published: (2017-05-01)

Small cell lung cancer transformation during immunotherapy with nivolumab: A case report
by: Takuma Imakita, et al.
Published: (2017-01-01)

Delayed Diagnosis of Eosinophilic Fasciitis: A case report and review of the literature
by: Elif Aydin, et al.
Published: (2015-04-01)

Brief Report on the Efficacy of Nivolumab in Patients With Previously Treated Advanced Large-Cell Neuroendocrine Cancer of the Lung
by: Camille Agar, MD, et al.
Published: (2021-04-01)

Dual checkpoint inhibitor-associated eosinophilic enteritis
by: J. Yang, et al.
Published: (2019-11-01)

Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients
by: Elisa Giommoni, et al.
Published: (2021-08-01)

Clinical utility of nivolumab in the treatment of advanced melanoma
by: Asmar R, et al.
Published: (2016-02-01)

Targeted Therapy with Sirolimus and Nivolumab in a Child with Refractory Multifocal Anaplastic Ependymoma
by: Katia Perruccio, et al.
Published: (2021-05-01)

Construction of a Ferroptosis-Related Gene Signature for Predicting Survival and Immune Microenvironment in Melanoma Patients
by: Zeng N, et al.
Published: (2021-10-01)

Autoimmune Hemolytic Anemia as a Complication of Nivolumab Therapy
by: Amruth R. Palla, et al.
Published: (2016-11-01)

Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients
by: Ilaria Grazia Zizzari, et al.
Published: (2020-11-01)

Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
by: Kuniyasu Takagi, et al.
Published: (2021-10-01)

Effectiveness of Tocilizumab in the Treatment of Fasciitis with Eosinophilia: Two Case Reports
by: Guiomar Pinheiro, et al.
Published: (2020-03-01)